Postoperative nutritional support after pancreaticoduodenectomy in adults.

IF 8.8 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Rachel H Robertson, Kylie Russell, Vanessa Jordan, Sanjay Pandanaboyana, Dong Wu, John Windsor
{"title":"Postoperative nutritional support after pancreaticoduodenectomy in adults.","authors":"Rachel H Robertson, Kylie Russell, Vanessa Jordan, Sanjay Pandanaboyana, Dong Wu, John Windsor","doi":"10.1002/14651858.CD014792.pub2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Resection of the head of the pancreas is most commonly done by a pancreaticoduodenectomy, known as a Whipple procedure. The most common indication for pancreaticoduodenectomy is malignancy, but can include benign tumours and chronic pancreatitis. Complete surgical resection, with negative margins, provides the best prospect of long-term survival. Pancreaticoduodenectomy involves specific and unique alterations to the digestive system and maintaining nutritional status (optimising outcomes and achieving resumption of a normal diet) in patients with cancer after major surgery is a challenge. Malnutrition is a risk factor following pancreaticoduodenectomy, due to the magnitude of the operation and the frequency of complications. Postoperatively, patients are fed either orally, enterally or parenterally. Oral intake may start with fluids and then progress to solid food, or may be ad libitum. Enteral feeding may be via a nasojejunal tube or feeding tube jejunostomy. Parenteral nutrition can be delivered via a central or peripheral intravenous line, and may provide full nutrition (TPN) or partial nutrition (supplemental PN).</p><p><strong>Objectives: </strong>To assess the effects of postoperative nutritional support strategies on complications and recovery in adults after pancreaticoduodenectomy.</p><p><strong>Search methods: </strong>We searched CENTRAL, MEDLINE, Embase, LILACS and CINAHL (from inception to October 2022), ongoing trials registers and other internet databases. We searched previous systematic reviews, relevant publications on the same topic and the references of included studies.</p><p><strong>Selection criteria: </strong>Randomised controlled trials of postoperative nutritional interventions in an inpatient setting for patients undergoing pancreaticoduodenectomy. We specifically looked for studies comparing route or timing rather than nutritional content.</p><p><strong>Data collection and analysis: </strong>Two review authors independently assessed studies for inclusion, judged the risk of bias and extracted data. Studies requiring translation were assessed for inclusion, risk of bias and data extraction by an external translator and another author. We used GRADE to evaluate the certainty of the evidence.</p><p><strong>Main results: </strong>We included 17 studies (1897 participants). Of these, eight studies could be included in a meta-analysis. The route, timing and target of nutritional support varied widely between studies. Enteral feeding (jejunostomy, nasojejunal or gastrojejunostomy) was used in at least 13 studies (one study did not specify the method of enteral route), parenteral nutrition (PN) was used in at least 10 studies (two studies had a control of 'surgeon's preference' and no further details were given) and oral intake was used in seven studies. Overall, the evidence presented in this review is of low to very low certainty. Four studies compared jejunostomy feeding with total parenteral nutrition. When we pooled these four studies, the evidence demonstrated that jejunostomy likely results in a reduced length of hospital stay (mean difference (MD) -1.61 days, 95% confidence interval (CI) -2.31 to -0.92; 3 studies, 316 participants; moderate-certainty evidence). The evidence suggested that there may be no difference in postoperative pancreatic fistula (risk ratio (RR) 0.77, 95% CI 0.41 to 1.47; 4 studies, 346 participants; low-certainty evidence) and that there may be no difference in delayed gastric emptying (RR 0.38, 95% CI 0.04 to 3.50; 2 studies, 270 participants; very low-certainty evidence) or post pancreatectomy haemorrhage (RR 0.36, 95% CI 0.06 to 2.29; 2 studies, 270 participants; very low-certainty evidence), but the evidence is uncertain. There were no data for major and minor complications defined by the Clavien-Dindo classification. Two studies compared nasojejunal feeding with total parenteral nutrition. When the two studies were pooled, the evidence suggested that there may be little to no difference between nasojejunal feeding and TPN in the length of hospital stay (MD 1.07 days, 95% CI -2.64 to 4.79; 2 studies, 242 participants; low-certainty evidence), delayed gastric emptying (RR 1.26, 95% CI 0.83 to 1.91; 2 studies, 242 participants; low-certainty evidence) or post pancreatectomy haemorrhage (RR 1.00, 95% CI 0.62 to 1.62; 2 studies, 242 participants; low-certainty evidence). TPN may slightly improve rates of clinically relevant postoperative pancreatic fistula (RR 2.13, 95% CI 1.21 to 3.74; 2 studies, 242 participants; low-certainty evidence). One study reported on major complications (RR 1.27, 95% CI 0.83 to 1.94; very low-certainty evidence) and minor complications (RR 1.01, 95% CI 0.68 to 1.50; 204 participants; very low-certainty evidence) defined by the Clavien-Dindo classification and there may be little to no difference in effect, but the evidence is uncertain. Two studies compared jejunostomy feeding with oral intake. Of note, one of the studies used a modified surgical technique as part of the intervention. We pooled these studies and found that there may be little to no difference in the length of hospital stay (MD -1.99 days, 95% CI -4.90 to 0.91; 2 studies, 301 participants; very low-certainty evidence) or delayed gastric emptying (RR 0.98, 95% CI 0.33 to 2.88; 2 studies, 307 participants; very low-certainty evidence). One study reported on major complications (RR 1.01, 95% CI 0.44 to 2.34; 247 participants; very low-certainty evidence) and minor complications (RR 0.83, 95% CI 0.59 to 1.15; 247 participants; very low-certainty evidence) defined by the Clavien-Dindo classification, postoperative pancreatic fistula (RR 0.86, 95% CI 0.30 to 2.50; 247 participants; very low-certainty evidence) and post pancreatectomy haemorrhage (RR 2.02, 95% CI 0.52 to 7.88; 247 participants; very low-certainty evidence) and there may be little to no difference in effect on these outcomes, but the evidence is uncertain. No difference in mortality was detected in any of the analyses (Clavien-Dindo Grade V) (very low-certainty evidence).</p><p><strong>Authors' conclusions: </strong>When compared with parenteral nutrition, enteral nutrition by jejunostomy likely results in a decreased length of hospital stay and may lead to no difference in the incidence of postoperative complications. When compared with parenteral nutrition, enteral feeding by nasojejunal tube may result in no difference in the incidence of postoperative complications or length of hospital stay. When compared with oral nutrition, enteral nutrition by jejunostomy feeding may result in no difference in the incidence of postoperative complications or length of hospital stay, but the evidence is very uncertain. Further high-quality research is required and there are several ongoing studies. Given the number of different nutritional interventions available in the postoperative setting, a network meta-analysis would be more appropriate in future.</p>","PeriodicalId":10473,"journal":{"name":"Cochrane Database of Systematic Reviews","volume":"3 ","pages":"CD014792"},"PeriodicalIF":8.8000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11907764/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cochrane Database of Systematic Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/14651858.CD014792.pub2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Resection of the head of the pancreas is most commonly done by a pancreaticoduodenectomy, known as a Whipple procedure. The most common indication for pancreaticoduodenectomy is malignancy, but can include benign tumours and chronic pancreatitis. Complete surgical resection, with negative margins, provides the best prospect of long-term survival. Pancreaticoduodenectomy involves specific and unique alterations to the digestive system and maintaining nutritional status (optimising outcomes and achieving resumption of a normal diet) in patients with cancer after major surgery is a challenge. Malnutrition is a risk factor following pancreaticoduodenectomy, due to the magnitude of the operation and the frequency of complications. Postoperatively, patients are fed either orally, enterally or parenterally. Oral intake may start with fluids and then progress to solid food, or may be ad libitum. Enteral feeding may be via a nasojejunal tube or feeding tube jejunostomy. Parenteral nutrition can be delivered via a central or peripheral intravenous line, and may provide full nutrition (TPN) or partial nutrition (supplemental PN).

Objectives: To assess the effects of postoperative nutritional support strategies on complications and recovery in adults after pancreaticoduodenectomy.

Search methods: We searched CENTRAL, MEDLINE, Embase, LILACS and CINAHL (from inception to October 2022), ongoing trials registers and other internet databases. We searched previous systematic reviews, relevant publications on the same topic and the references of included studies.

Selection criteria: Randomised controlled trials of postoperative nutritional interventions in an inpatient setting for patients undergoing pancreaticoduodenectomy. We specifically looked for studies comparing route or timing rather than nutritional content.

Data collection and analysis: Two review authors independently assessed studies for inclusion, judged the risk of bias and extracted data. Studies requiring translation were assessed for inclusion, risk of bias and data extraction by an external translator and another author. We used GRADE to evaluate the certainty of the evidence.

Main results: We included 17 studies (1897 participants). Of these, eight studies could be included in a meta-analysis. The route, timing and target of nutritional support varied widely between studies. Enteral feeding (jejunostomy, nasojejunal or gastrojejunostomy) was used in at least 13 studies (one study did not specify the method of enteral route), parenteral nutrition (PN) was used in at least 10 studies (two studies had a control of 'surgeon's preference' and no further details were given) and oral intake was used in seven studies. Overall, the evidence presented in this review is of low to very low certainty. Four studies compared jejunostomy feeding with total parenteral nutrition. When we pooled these four studies, the evidence demonstrated that jejunostomy likely results in a reduced length of hospital stay (mean difference (MD) -1.61 days, 95% confidence interval (CI) -2.31 to -0.92; 3 studies, 316 participants; moderate-certainty evidence). The evidence suggested that there may be no difference in postoperative pancreatic fistula (risk ratio (RR) 0.77, 95% CI 0.41 to 1.47; 4 studies, 346 participants; low-certainty evidence) and that there may be no difference in delayed gastric emptying (RR 0.38, 95% CI 0.04 to 3.50; 2 studies, 270 participants; very low-certainty evidence) or post pancreatectomy haemorrhage (RR 0.36, 95% CI 0.06 to 2.29; 2 studies, 270 participants; very low-certainty evidence), but the evidence is uncertain. There were no data for major and minor complications defined by the Clavien-Dindo classification. Two studies compared nasojejunal feeding with total parenteral nutrition. When the two studies were pooled, the evidence suggested that there may be little to no difference between nasojejunal feeding and TPN in the length of hospital stay (MD 1.07 days, 95% CI -2.64 to 4.79; 2 studies, 242 participants; low-certainty evidence), delayed gastric emptying (RR 1.26, 95% CI 0.83 to 1.91; 2 studies, 242 participants; low-certainty evidence) or post pancreatectomy haemorrhage (RR 1.00, 95% CI 0.62 to 1.62; 2 studies, 242 participants; low-certainty evidence). TPN may slightly improve rates of clinically relevant postoperative pancreatic fistula (RR 2.13, 95% CI 1.21 to 3.74; 2 studies, 242 participants; low-certainty evidence). One study reported on major complications (RR 1.27, 95% CI 0.83 to 1.94; very low-certainty evidence) and minor complications (RR 1.01, 95% CI 0.68 to 1.50; 204 participants; very low-certainty evidence) defined by the Clavien-Dindo classification and there may be little to no difference in effect, but the evidence is uncertain. Two studies compared jejunostomy feeding with oral intake. Of note, one of the studies used a modified surgical technique as part of the intervention. We pooled these studies and found that there may be little to no difference in the length of hospital stay (MD -1.99 days, 95% CI -4.90 to 0.91; 2 studies, 301 participants; very low-certainty evidence) or delayed gastric emptying (RR 0.98, 95% CI 0.33 to 2.88; 2 studies, 307 participants; very low-certainty evidence). One study reported on major complications (RR 1.01, 95% CI 0.44 to 2.34; 247 participants; very low-certainty evidence) and minor complications (RR 0.83, 95% CI 0.59 to 1.15; 247 participants; very low-certainty evidence) defined by the Clavien-Dindo classification, postoperative pancreatic fistula (RR 0.86, 95% CI 0.30 to 2.50; 247 participants; very low-certainty evidence) and post pancreatectomy haemorrhage (RR 2.02, 95% CI 0.52 to 7.88; 247 participants; very low-certainty evidence) and there may be little to no difference in effect on these outcomes, but the evidence is uncertain. No difference in mortality was detected in any of the analyses (Clavien-Dindo Grade V) (very low-certainty evidence).

Authors' conclusions: When compared with parenteral nutrition, enteral nutrition by jejunostomy likely results in a decreased length of hospital stay and may lead to no difference in the incidence of postoperative complications. When compared with parenteral nutrition, enteral feeding by nasojejunal tube may result in no difference in the incidence of postoperative complications or length of hospital stay. When compared with oral nutrition, enteral nutrition by jejunostomy feeding may result in no difference in the incidence of postoperative complications or length of hospital stay, but the evidence is very uncertain. Further high-quality research is required and there are several ongoing studies. Given the number of different nutritional interventions available in the postoperative setting, a network meta-analysis would be more appropriate in future.

成人胰十二指肠切除术后的营养支持。
背景:胰头切除术最常采用胰十二指肠切除术,即惠普尔手术。胰十二指肠切除术最常见的适应症是恶性肿瘤,但也可能包括良性肿瘤和慢性胰腺炎。完全手术切除,阴性切缘,提供了长期生存的最佳前景。胰十二指肠切除术涉及到对消化系统的特殊和独特的改变,并且在大手术后维持癌症患者的营养状态(优化结果并恢复正常饮食)是一项挑战。由于胰十二指肠切除术的规模和并发症的频率,营养不良是胰十二指肠切除术后的一个危险因素。术后,患者可口服、肠内或肠外进食。口腔摄入可能从液体开始,然后发展到固体食物,或者可能是随意的。肠内喂养可通过鼻空肠管或喂养管空肠造口。肠外营养可通过中心静脉或外周静脉输送,并可提供完全营养(TPN)或部分营养(补充PN)。目的:评价成人胰十二指肠切除术后营养支持策略对并发症及康复的影响。检索方法:检索CENTRAL, MEDLINE, Embase, LILACS和CINAHL(从成立到2022年10月),正在进行的试验注册和其他互联网数据库。我们检索了以前的系统综述、同一主题的相关出版物以及纳入研究的参考文献。选择标准:胰十二指肠切除术患者住院后营养干预的随机对照试验。我们特别寻找比较路线或时间的研究,而不是营养成分。数据收集和分析:两位综述作者独立评估纳入研究,判断偏倚风险并提取数据。需要翻译的研究由外部翻译人员和另一位作者评估纳入、偏倚风险和数据提取。我们使用GRADE来评估证据的确定性。主要结果:我们纳入了17项研究(1897名参与者)。其中,8项研究可以纳入荟萃分析。在不同的研究中,营养支持的途径、时间和目标差异很大。至少有13项研究使用了肠内喂养(空肠造口术、鼻空肠造口术或胃空肠造口术)(一项研究没有指定肠内途径的方法),至少10项研究使用了肠外营养(两项研究控制了“外科医生的偏好”,没有给出进一步的细节),7项研究使用了口服摄入。总的来说,本综述中提出的证据的确定性低至极低。四项研究比较了空肠造口喂养和全肠外营养。当我们汇总这四项研究时,证据表明空肠造口术可能导致住院时间缩短(平均差(MD) -1.61天,95%置信区间(CI) -2.31至-0.92;3项研究,316名受试者;moderate-certainty证据)。有证据表明,两组患者术后胰瘘发生率可能无差异(风险比(RR) 0.77, 95% CI 0.41 ~ 1.47;4项研究,346名受试者;低确定性证据),在胃排空延迟方面可能没有差异(RR 0.38, 95% CI 0.04 ~ 3.50;2项研究,270名参与者;极低确定性证据)或胰切除术后出血(RR 0.36, 95% CI 0.06至2.29;2项研究,270名参与者;非常低确定性的证据),但证据是不确定的。没有Clavien-Dindo分类定义的主要和次要并发症的数据。两项研究比较了鼻空肠喂养和全肠外营养。当两项研究合并时,证据表明鼻空肠喂养和TPN在住院时间上可能几乎没有差异(MD 1.07天,95% CI -2.64至4.79;2项研究,242名受试者;低确定性证据),胃排空延迟(RR 1.26, 95% CI 0.83 - 1.91;2项研究,242名受试者;低确定性证据)或胰切除术后出血(RR 1.00, 95% CI 0.62至1.62;2项研究,242名受试者;确定性的证据)。TPN可略微改善临床相关的术后胰瘘发生率(RR 2.13, 95% CI 1.21 ~ 3.74;2项研究,242名受试者;确定性的证据)。一项研究报告了主要并发症(RR 1.27, 95% CI 0.83 ~ 1.94;极低确定性证据)和轻微并发症(RR 1.01, 95% CI 0.68 ~ 1.50;204名参与者;非常低确定性的证据)由Clavien-Dindo分类定义,效果可能几乎没有差异,但证据是不确定的。两项研究比较了空肠造口喂养和口服喂养。值得注意的是,其中一项研究使用了改良的手术技术作为干预的一部分。 我们汇总了这些研究,发现住院时间可能几乎没有差异(MD -1.99天,95% CI -4.90至0.91;2项研究,301名受试者;极低确定性证据)或胃排空延迟(RR 0.98, 95% CI 0.33 - 2.88;2项研究,307名受试者;非常低确定性证据)。一项研究报告了主要并发症(RR 1.01, 95% CI 0.44 ~ 2.34;247名参与者;极低确定性证据)和轻微并发症(RR 0.83, 95% CI 0.59 ~ 1.15;247名参与者;极低确定性证据),术后胰瘘(RR 0.86, 95% CI 0.30至2.50;247名参与者;极低确定性证据)和胰切除术后出血(RR 2.02, 95% CI 0.52至7.88;247名参与者;非常低确定性的证据),对这些结果的影响可能很少或没有差异,但证据是不确定的。在任何分析中均未发现死亡率差异(Clavien-Dindo Grade V)(极低确定性证据)。作者的结论是:与肠外营养相比,空肠造口肠内营养可能缩短住院时间,并可能导致术后并发症的发生率无差异。与肠外营养相比,鼻空肠管肠内喂养在术后并发症发生率和住院时间上没有差异。与口服营养相比,空肠造口喂养的肠内营养在术后并发症发生率和住院时间上可能没有差异,但证据非常不确定。需要进一步的高质量研究,目前有几项研究正在进行中。考虑到术后可采用的不同营养干预措施的数量,网络荟萃分析将在未来更为合适。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.60
自引率
2.40%
发文量
173
审稿时长
1-2 weeks
期刊介绍: The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信